Literature DB >> 18310399

Interstitial lung diseases in infants and children.

A Clement1, E Eber.   

Abstract

Interstitial lung disease (ILD) in infants and children represents a heterogeneous group of respiratory disorders that are mostly chronic and associated with high morbidity and mortality. Typical features of ILD include dyspnoea, the presence of diffuse infiltrates on chest radiographs and abnormal pulmonary function tests with evidence of a restrictive ventilatory defect (in older children) and/or impaired gas exchange. ILD is difficult to diagnose, as no classification scheme is entirely satisfactory. Recently, it has been proposed to categorise paediatric ILD as either primary pulmonary disorders or systemic disorders with pulmonary involvement. However, this classification leaves the difficult problem of which clinical conditions should be included or excluded in infants and children. The present article reviews interstitial lung disease in infants and children, placing emphasis on current concepts of pathophysiological mechanisms and approaches to treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310399     DOI: 10.1183/09031936.00004707

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

1.  A novel surfactant protein C mutation resulting in aberrant protein processing and altered subcellular localization causes infantile interstitial lung disease.

Authors:  Da Hong; Yuanyuan Qi; Jing Liu; Huijun Wang; Libo Wang; Liling Qian
Journal:  Pediatr Res       Date:  2017-02-03       Impact factor: 3.756

2.  Autoimmune pulmonary proteinosis in a Chilean teenager, a rare aetiology of interstitial lung disease.

Authors:  Alexis Strickler; Maria Lina Boza; Andres Koppmann; Sergio Gonzalez
Journal:  BMJ Case Rep       Date:  2014-05-23

Review 3.  Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis.

Authors:  Robin R Deterding; Emily M DeBoer; Michal J Cidon; Terry E Robinson; David Warburton; Gail H Deutsch; Lisa R Young
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

4.  CT features of diffuse lung disease in infancy.

Authors:  Paolo Toma; Aurelio Secinaro; Oliviero Sacco; Davide Curione; Renato Cutrera; Nicola Ullmann; Claudio Granata
Journal:  Radiol Med       Date:  2018-03-22       Impact factor: 3.469

5.  Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany.

Authors:  Matthias Griese; Melanie Haug; Frank Brasch; Achim Freihorst; Peter Lohse; Rüdiger von Kries; Theodor Zimmermann; Dominik Hartl
Journal:  Orphanet J Rare Dis       Date:  2009-12-12       Impact factor: 4.123

6.  A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling.

Authors:  Markus Woischnik; Christiane Sparr; Sunčana Kern; Tobias Thurm; Andreas Hector; Dominik Hartl; Gerhard Liebisch; Surafel Mulugeta; Michael F Beers; Gerd Schmitz; Matthias Griese
Journal:  BMC Cell Biol       Date:  2010-11-20       Impact factor: 4.241

Review 7.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

8.  Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells.

Authors:  Nina Weichert; Eva Kaltenborn; Andreas Hector; Markus Woischnik; Andrea Schams; Andreas Holzinger; Sunčana Kern; Matthias Griese
Journal:  Respir Res       Date:  2011-01-07

9.  Toxic inhalational injury-associated interstitial lung disease in children.

Authors:  Eun Lee; Ju-Hee Seo; Hyung Young Kim; Jinho Yu; Won-Kyoung Jhang; Seong-Jong Park; Ji-Won Kwon; Byoung-Ju Kim; Kyung-Hyun Do; Young Ah Cho; Sun-A Kim; Se Jin Jang; Soo-Jong Hong
Journal:  J Korean Med Sci       Date:  2013-06-03       Impact factor: 2.153

10.  Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD).

Authors:  Chatarina Löfqvist; Gunnel Hellgren; Aimon Niklasson; Eva Engström; David Ley; Ingrid Hansen-Pupp
Journal:  Acta Paediatr       Date:  2012-09-10       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.